R.N. Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.91 Cr
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 152.00 Cr
- Satisfied Charges ₹ 38.50 Cr
- Revenue Growth 46.97%
- Profit Growth 428.59%
- Ebitda 821.64%
- Net Worth 6.33%
- Total Assets 13.96%
About R.N. Laboratories
R.N. Laboratories Private Limited (RLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 December 1998 and has a history of 26 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Sky Chem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.91 Cr.
The company currently has active open charges totaling ₹152.00 Cr. The company has closed loans amounting to ₹38.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at R.N. Laboratories Private Limited India is Amruta Kulkarni as COMPANY SECRETARY. Rohit Garg, Nitin Garg, Vikram Vyas, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24200MH1998PTC117339
- Company No.
117339
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 1998
- Date of AGM
03 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at R.N. Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amruta Kulkarni | Company Secretary | 26-Mar-2022 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohit Garg  | Director | 04-Dec-1998 | Current |
| Nitin Garg | Director | 04-Dec-1998 | Current |
| Vikram Vyas | Director | 15-Dec-2016 | Current |
| Sanket Sawant | Director | 30-Jul-2021 | Current |
Financial Performance of R.N. Laboratories.
R.N. Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.97% increase. The company also saw a substantial improvement in profitability, with a 428.59% increase in profit. The company's net worth moved up by a moderate rise of 6.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R.N. Laboratories?
In 2023, R.N. Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Garonit Pharmaceuticals Private LimitedRohit Garg, Nitin Garg and 1 more are mutual person
- Neelam Garg Foundation
Nitin Garg and Vikram Vyas are mutual person
Charges (Loans)
₹152.00 Cr
₹38.50 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 102.00 Cr
- Hdfc Bank Limited : 50.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2023 | Hdfc Bank Limited | ₹25.00 Cr | Open |
| 05 Jan 2023 | Hdfc Bank Limited | ₹25.00 Cr | Open |
| 03 Aug 2019 | Citi Bank N.A. | ₹60.00 Cr | Open |
| 28 Aug 2017 | Citi Bank N.A. | ₹2.00 Cr | Open |
| 30 Dec 2014 | Citi Bank N.A. | ₹40.00 Cr | Open |
How Many Employees Work at R.N. Laboratories?
R.N. Laboratories has a workforce of 242 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R.N. Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R.N. Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
